Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F. M., Remme, W. J., Cody, R. J., Castaigne, A., Pérez, A. J. P., Palensky, J., & Wittes, J. T. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604

Antihypertensive drugs

Coleman, J. J., & Martin, U. (2008) · Side effects of drugs annual · doi:10.1016/s0378-6080(08)00020-2

Hypertension

FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch11

Microvascular Complications

(2007) · Endocrine Practice · doi:10.1016/s1530-891x(20)46427-4

Algemene problemen

Gans, R. O. B., & Hoekstra, J. B. L. (2015) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0923-8_1

Algemene problemen

Gans, R. O. B., & Hoekstra, J. B. L. (2015) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0554-4_1

Équilibre potassique. Hypokaliémie et hyperkaliémie

Dussol, B. (2006) · Encyclopédie médico-chirurgicale. Néphrologie · doi:10.1016/s1762-0945(08)48900-3

Managing persistent hyperkalaemia with next-generation potassium binders

Rossignol, P., Bhandari, S., Kalra, P. A., Selwood, J., Hinchliffe, W., & Maxfield, D. (2022) · Journal of Kidney Care · doi:10.12968/jokc.2022.7.sup2.s1

Assessment of Biochemical Parameters, Kidney Function, and Long-term Outcome in Renal Transplant Recipients

Ahmad, S., Sailaja, K., Reddy, P. P., & Gaddam, S. (2022) · Asian Pacific Journal of Health Sciences · doi:10.21276/apjhs.2022.9.4s1.09

Vía de administración inusual de ciclosilicato de sodio y zirconio a través de sonda nasogástrica. A propósito de un caso

Iglesias, M. B., García, E. B., & Pedrinaci, E. Z. (2023) · Nefrología · doi:10.1016/j.nefro.2023.08.009

Effectiveness of Chinese herbal medicine compared with angiotensin II receptor blockers in patients with diabetic kidney disease: A hospital-based matched cohort study

Liao, Y.-C., Wu, M., Huang, Y., Chou, C., & Yen, H. (2023) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2023.11.002

Dyskalaemia in heart failure

Ferreira, J. P., Damman, K., Müllens, W., & Butler, J. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780198891628.003.0067

Exploring electrolyte imbalances in cataractogenesis: A comparative analysis of sodium and potassium levels in diabetic and non-diabetic patients

Choppara, B., Kumar, I. V., Badam, A., & Sultana, S. (2024) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v15i1.58034

Modernes Kaliummanagement der chronischen Hyperkaliämie

Brand, M. (2024) · Die Nephrologie · doi:10.1007/s11560-024-00718-1

Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial

Mårup, F. H., Peters, C. D., Nielsen, S. F., Nygaard, L. B., Madsen, B., Mose, F. H., & Birn, H. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.05.006

Dispotasemias del adulto

Ichaï, C. (2024) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(24)49621-7

Diskaliemie dell’adulto

Ichaï, C. (2024) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(24)49600-x

Therapie einer chronischen Hyperkaliämie

Babic, M. (2025) · CardioVasc · doi:10.1007/s15027-024-3713-x

AN ATTEMPT TO UNVEIL THE PHARMACEUTICAL ASPECTS OF SHWETA PARPATI AND ITS BROAD-SPECTRUM CLINICAL UTILITY – A SHORT REVIEW

(2025) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2025/14.5.8972

A patient with SLE-associated late-onset cirrhosis, thrombocytopenia and type 4 renal tubular acidosis: A rare case

Murat, A. Y. (2025) · Next research. · doi:10.1016/j.nexres.2025.100553

An unusual case of drug-induced hyperkalemia presenting as ascending paralysis: a case report and review of literature

Angirekula, S., Bhellum, P., Rohila, A. K., & Dholavan, M. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00515-9

A

Cade, J. F. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511835278.002

Additional file 1 of A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia

Cañas, A. E., Troutt, H. R., Jiang, L., Tonthat, S., Darwish, O. S., Ferrey, A., Lotfipour, S., Kalantar-Zadeh, K., Hanna, R., & Lau, W. L. (2023) · Figshare · doi:10.6084/m9.figshare.22620307

Additional file 1 of Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes

Khan, M. S., & Lea, J. P. (2024) · Figshare · doi:10.6084/m9.figshare.26461829

Reprint of: Chronic Kidney Disease in Diabetes: A Clinical Practice Guideline

Tobe, S. W., BAJAJ, H. S., Tangri, N., Jain, R., Pham, T., Beaudin, V., & McFarlane, P. (2025) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2025.12.004

Polypharmacy and Potential Drug–Drug Interactions among Ischemic Heart Disease Patients with Comorbidities: A Cross-Sectional Study from a Tertiary Care Center in Eastern India

Rahaman, S. S., Bag, R., & Naskar, S. (2025) · Amrita Journal of Medicine · doi:10.4103/amjm.amjm_94_25

Dyskaliémie : fréquence, pronostic, prise en charge et iatrogénèse

Vuillaume, L. A. (2020) · doi:10.70675/ff71c84dzba42z4055zb9ffz091323b2808b

Diagnostic Overlap Between Uremia and Severe Hyperkalemia in Chronic Kidney Disease: Emphasizing Laboratory-Guided Urgency Despite Absent EKG Changes

Tahir, M. H., Tahir, F., Tahir, M. M., Imran, A., & Asghar, S. (2026) · Cureus · doi:10.7759/cureus.107246

Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases

Chui, Z. S. W., Xue, Y., Wu, X., & Xu, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100150

Patient and Clinician Perspectives on Hyperkalemia Management Under Cardio-Kidney-Protective Therapy: A Three-Stakeholder Cross-Sectional Survey

Yi, Y., Baek, S. H., Lee, J., & Kim, S. (2026) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2026.24.e9

Sodium-Glucose Co-Transporter 2 Inhibitors and Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors During Mineralocorticoid Receptor Antagonist Therapy: A Real-World Cohort Study

Almalki, A. H., Alorainan, N. A., Bukhari, M. A., Dokhaikh, F. A. A., Quqandi, S. M. A., Merdad, R. H., & Sadagah, L. F. (2026) · Pharmacy · doi:10.3390/pharmacy14040091

Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin–Angiotensin System Inhibitors

Crum, K. L., Vaduganathan, M., & Desai, R. J. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70382

Hemodynamic effects of finerenone on blood pressure and heart rate in hospitalized patients with type 2 diabetes: a real-world study

Wen, S., Yun, D., He, Y., Li, X. I. A. O., Chen, L., Wang, C., Zhu, Y., Xu, D., Liu, D., Li, J., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1878697

Development of a nomogram for predicting hyperkalemia in advanced chronic kidney disease

Chavez-Iñiguez, J. S., Ornelas-Ruvalcaba, R. L., Rodríguez-García, G., Navarro‐Blackaller, G., Medina-González, R., Gallardo-González, A. M., Alcantar-Vallin, L., Abundis-Mora, G. J., Gómez-Fregoso, J. A., García-García, G., et al. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2709935

Factors Associated with Hyperkalemia in Chronic Kidney Disease: Insights from a Cohort with Measured Glomerular Filtration Rate

Motiejūnaitė, J., Flamant, M., Lahens, A., Fearon, T., Tabibzadeh, N., Boutten, A., Vrtovsnik, F., Stengel, B., de Pinho, N. A., & Vidal‐Petiot, E. (2026) · American Journal of Nephrology · doi:10.1159/ajn/ablag008

Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1 ‐Dependent Suppression of ROMK

Kawarazaki, W., Ayuzawa, N., Nishimoto, M., Hirohama, D., Ueda, K., Marumo, T., & Fujita, T. (2026) · Acta Physiologica · doi:10.1111/apha.70325

Fluid and Electrolyte Disorders

Assadi, F. K. (2007) · Springer eBooks · doi:10.1007/978-0-387-74602-9_1

Minimize drug-induced hyperkalaemia by increasing awareness and using preventative strategies

Writers, A. M. (2014) · Drugs & Therapy Perspectives · doi:10.1007/s40267-014-0171-z

Monitoring of patients for the development of adverse reactions to antihypertensive drugs in general practice

McDowell, S. E. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham)

Systematic Review Of Hyperkalemia Due To Angiotensin Enzyme Converting Inhibitors

Aggarwal, S., Topaloglu, H., & Kumar, S. (2015) · Value in Health · doi:10.1016/j.jval.2015.09.898

Systematic Review of Burden of Hyperkalemia due to Angiotensin Enzyme Converting Inhibitors

Aggarwal, S., Kumar, S., & Topaloglu, H. (2016) · Value in Health · doi:10.1016/j.jval.2016.03.082

Hyperkalemia and Inhibitors of the Renin–Angiotensin–Aldosterone System

Segal, A. Z. (2004) · New England Journal of Medicine · doi:10.1056/nejm200412023512321 · Cited by 2

Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Closer Look at Hyperkalemia

Chung, S., & Park, C. W. (2011) · The Korean Journal of Internal Medicine

Hyperkalemia Associated with Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

Raebel, M. A. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00258.x · Cited by 190